Medivir AB (publ) (LON:0GP7)
London · Delayed Price · Currency is GBP · Price in SEK 0.4035
-0.0545 (-11.90%)
Dec 9, 2025, 12:28 PM BST
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 3.77 million as of December 9, 2025. Its market cap has decreased by -82.64% in one year.
Market Cap
3.77M
Enterprise Value
2.42M
Revenue
314.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
Market Cap Chart
Since April 30, 1999, Medivir AB's market cap has decreased from 47.34M to 3.77M, a decrease of -92.03%. That is a compound annual growth rate of -9.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 3.77M | -83.64% |
| Dec 30, 2024 | 23.05M | 86.09% |
| Dec 29, 2023 | 12.39M | -71.80% |
| Dec 30, 2022 | 43.92M | -14.08% |
| Dec 30, 2021 | 51.12M | 182.66% |
| Dec 30, 2020 | 18.09M | -26.47% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.47B |
| Haleon | 32.12B |
| Smith & Nephew | 10.72B |
| Convatec Group | 4.47B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.83B |
| Genus | 1.73B |